Cizzle Biotechnology (LON:CIZ) Shares Down 11.1% – Should You Sell?

Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ) fell 11.1% during trading on Tuesday . The stock traded as low as GBX 2 and last traded at GBX 2. 75,237 shares traded hands during mid-day trading, a decline of 92% from the average session volume of 947,546 shares. The stock had previously closed at GBX 2.25.

Cizzle Biotechnology Trading Down 11.1%

The stock has a market cap of £7.93 million, a P/E ratio of -6.25 and a beta of 0.51. The stock’s 50-day moving average is GBX 1.64 and its two-hundred day moving average is GBX 1.60. The company has a debt-to-equity ratio of -54.35, a current ratio of 0.48 and a quick ratio of 4.66.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.